So far, China has made no official public threat about weaponizing its dominant position in this segment of the pharmaceutical industry. But Trump’s tariffs on the sector, if imposed, could worsen ...

Notably, the U.S.’ two primary biopharma trade groups—the Pharmaceutical Research and Manufacturers of America (PhRMA) and ...

US President Donald Trump on May 23 threatened to impose a 50 percent tariff on all imports from the European Union.

U.S. drug companies are increasingly licensing experimental medicines invented by Chinese firms. Recent deals could be worth ...

Joseph Wolk told an investor conference that the company’s tariff estimate is a “moving target” as trade talks continue with ...

How pharmaceutical tariffs could reshape drug pricing, supply chains and domestic production in the United States, according ...

While the Trump administration’s threat of pharmaceutical import tariffs and most favored nation (MFN) drug pricing has ...

The pharmaceutical industry is bracing for chaos if President Trump follows through on his threat to impose ... in place escalating tariffs on imports from China, raising them to 145 percent ...

In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, ...

Mr. Trump said in remarks to reporters on Monday that pharmaceutical ... tariffs Mr. Trump announced earlier this month and then partly delayed for 90 days. Drugmakers importing from China into ...

So far, China has made no official public threat about weaponizing its dominant position in this segment of the pharmaceutical industry. But Trump’s tariffs on the sector, if imposed ...